Drug Database
Back to search

Belgium· BE-AMP-SAM106102-00

Dixarit 0.025 mg

A clonidine product containing clonidine hydrochloride, registered in Belgium by Boehringer Ingelheim. The same ATC class is registered in 5 of our 19 countries.

ATC N02CX02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDixarit 0.025 mgATCN02CX02REGISTER NO.BE-AMP-SAM106102-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clonidine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clonidine is registered in 5 of 19 countries.

Countries holding a registration under ATC N02CX02 (clonidine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search clonidine products by name

Clonidine · ATC N02CX02

5 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Clonidine Hydrochloride
Manufacturer
Boehringer Ingelheim
Country
Belgium (BE)
ATC code
N02CX02
ATC class
Clonidine
Defined daily dose
0.1 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0036889

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

306 interactions on record for clonidine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clonidine against other medicinesHow interaction checks work

Clonidine · interactions on record

306 records

  • 2 severe
  • 127 moderate
  • 2 minor
  • 175 info

Most severe, free to view

  • DoxepinD04AX01severe
  • DoxepinN06AA12severe
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clonidine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clonidine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Catapresan
  • Bulgaria · Хлофазолин
  • Czechia · Clonidine Olikla
  • Germany · Alcaridin, Catapresan
  • Denmark · Caruxin, Clopressan
  • Spain · Catapresan
  • Finland · Catapresan, Clonidine Macure
  • France · Catapressan
  • United Kingdom (Northern Ireland) · Calotep, Catapres
  • Greece · Catapresan
  • Ireland · Catapres, Catapres Ampoules
  • Italy · Catapresan, Catapresan Tts-1
  • Luxembourg · Catapressan
  • Latvia · Chlophazolin
  • Malta · Alcaridin, Catapres Tablets
  • Netherlands · Catapresan, Clonidine Hcl Cf
  • Norway · Caruxin, Clotaxip
  • Poland · Iporel
  • Portugal · Catapresan, Edolglau
  • Romania · Clonidină Arena, Clonidina Sintofarm
  • Sweden · Caruxin, Catapresan
  • Slovakia · Clonidine Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/491ad45c-5846-4446-a10b-b6c5061e4611
GET /v1/drugs/491ad45c-5846-4446-a10b-b6c5061e4611?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Dixarit 0.025 mg",
  "name_fr": "Dixarit 0.025 mg",
  "name_nl": "Dixarit 0.025 mg",
  "amp_code": "SAM106102-00",
  "strengths": [
    "25.0000",
    "25.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Clonidine Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Clonidine",
  "authorisation_numbers": [
    "BE106102"
  ]
}
API referenceMCP serverPlans

See everything about clonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console